A carregar...
Bispecific antibodies for cancer therapy: The light at the end of the tunnel?
With 23 approvals in the US and other countries and four approvals outside US, antibodies are now widely recognized as therapeutic molecules. The therapeutic and commercial successes met by rituximab, trastuzumab, cetuximab and other mAbs have inspired antibody engineers to improve the efficacy of t...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2791310/ https://ncbi.nlm.nih.gov/pubmed/20073127 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|